Gilead Sciences Inc (GILD) Stock Price, Quote & News

Company Profile

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis....

Industry: Drug Manufacturers - General

Sector: Healthcare

Phone: 650 574 3000

Fax: 650 578 9264

Website: www.gilead.com

Address:

333 Lakeside Drive, Foster City, United States

TheClockworkGroup Oct. 24 at 10:37 PM

$GILD 🚀#NASDAQ | Take your trading edge to the next level with #MilanO — one of our newest #AI-driven, #algorithmic #daytrading strategies! #GileadSciencesInc., $GILD, 2 for 2, scalped +$1,305.00 in today's session. Now you can too! Harness 100% automation with seamless integration across @MultiCharts, @NinjaTrader, @TradeStation & @TradingView platforms....

0 · Reply

adolphfrank Oct. 24 at 9:41 PM

$GILD GILD 5M Short CounterTrend Daytrade (Buy Put to Open) 5M CT: Long impulse, exhaustion volume. 1H CT: Long impulse, volumed T1, resistance zone, reaction bar. 1D CT: Long impulse, unvolumed T1, resistance level, manipulation bar. 1M CT: Long impulse, volumed T1 level, resistance zone. 1Y CT: Long impulse, unvolumed T1, resistance zone.

0 · Reply

GettnFibbywIT Oct. 24 at 6:57 PM

$XLV $SPY $GILD Kick save...And a beauty! Let's see if more shots on goal are coming below... of if price can stabilize around here sports fans:

0 · Reply

Dachshundtrader Oct. 24 at 5:08 PM

$ASMB up ~8% on almost no volume today. Not hype, not noise — just what happens when a tiny float meets a bit of quiet accumulation. Sometimes the calmest days say the most. $GILD

0 · Reply

StockOracle22 Oct. 24 at 4:29 PM

$MRK $AMGN $GILD

0 · Reply

JFDI Oct. 24 at 2:15 PM

$GILD nice hold of the 20dma

0 · Reply

Reanimated666 Oct. 24 at 1:43 PM

$GILD Fuckery

0 · Reply

RunnerSignals Oct. 24 at 10:39 AM

Wall Street Futures Steady Into CPI $INTC $F $GOOGL $GILD $TSLA making moves after hours. Intel finally alive, Ford shrugs off guidance cuts. https://stocksrunner.com/news/2025-10-24-wall-street-futures-steady-as-traders-eye-delayed-cpi

0 · Reply

LiquidThetaLEAPS Oct. 24 at 8:01 AM

LiquidTheta® LEAPS LIVE Actionable Alert Asset: $GILD Current Share Price: $119.69 Contracts: $GILD January 15, 2027 $120 Calls Scale in: $14.91- $18.22 Scale out: $23.19-$29.81 Can Easily Capture: 60% ROI Blended DTE: 449 Days | Join Elites here: https://liquidtheta.com/options

0 · Reply

SamanthaHayward Oct. 24 at 1:22 AM

$GILD Success doesn’t happen overnight; it’s all about taking small steps! Stay steady and keep up your efforts. You’ve got this! @SamanthaHayward

0 · Reply

What To Expect From Gilead In Q3 2025

Oct 23, 2025, 8:00 AM EDT - 2 days ago

Gilead to Showcase Interim Long-Term Efficacy Data for Livdelzi® (Seladelpar) in Primary Biliary Cholangitis (PBC) and Investigational Bulevirtide in Chronic Hepatitis Delta

Oct 21, 2025, 6:21 PM EDT - 3 days ago

Final Trade: F, HAL, MA, GILD

F HAL MA

Oct 21, 2025, 6:30 AM EDT - 4 days ago

AHF: 80 Organizations Denounce Gilead on Price Hikes Gutting ADAP

Oct 19, 2025, 8:30 AM EDT - 5 days ago

Gilead to Spotlight New Virology Data Across HIV, Viral Hepatitis and Respiratory Diseases at IDWeek 2025

Oct 19, 2025, 2:33 AM EDT - 6 days ago

Gilead's Trodelvy cuts breast cancer risk by 38% in trial

Oct 19, 2025, 2:30 AM EDT - 6 days ago

Trodelvy® Reduces Risk of Disease Progression or Death by 38% Versus Chemotherapy as First-Line Therapy in Patients With Metastatic Triple-Negative Breast Cancer in ASCENT-03 Study

Oct 18, 2025, 10:00 PM EDT - 6 days ago

Gilead Sciences Breaks Out To Record Highs, The Rally Has Room To Run

Oct 15, 2025, 3:30 AM EDT - 10 days ago

Gilead Presents New HIV Research Data at EACS 2025 – Driving Scientific Innovation in Treatment and Prevention

Oct 13, 2025, 10:33 AM EDT - 11 days ago

Gilead Sciences/Arcus Biosciences' Investigational Cancer Drug Shows Overall Survival Of Around 27 Months

Oct 13, 2025, 8:30 AM EDT - 11 days ago

Gilead and Kite Reinforce Bold Commitment to Transform Cancer Care With New Data at ESMO 2025

Oct 10, 2025, 1:44 PM EDT - 14 days ago

Final Trades: Gilead, Rocket Lab, Palo Alto and Coinbase

COIN PANW RKLB

Oct 9, 2025, 4:05 PM EDT - 15 days ago

Gilead Sciences to Release Third Quarter 2025 Financial Results on Thursday, October 30, 2025

Oct 6, 2025, 1:29 PM EDT - 18 days ago

My Top 5 Biotech Stocks Big Pharma Could Buy Next

ABBV ALVO AMGN ARKG AZN BIIB BMY

Sep 30, 2025, 12:55 PM EDT - 24 days ago

Dividend Shields: Top 5 Income Stocks

ALEX LTC OMF THG

Sep 29, 2025, 5:45 AM EDT - 26 days ago

Hanmi's Oral Delivery Platform Compound Licensed to Gilead

Sep 26, 2025, 1:47 PM EDT - 4 weeks ago

Pharma tariffs still have a lot of questions outstanding, says Bernstein's Courtney Breen

ABBV AMGN LLY MRK MRNA PFE

Sep 25, 2025, 8:00 AM EDT - 4 weeks ago

Gilead Foundation Grants $6.5 Million in Commitment to STEM Education

Sep 23, 2025, 6:45 PM EDT - 4 weeks ago

Gilead Sciences: Yeztugo And Trodelvy Make This A Buy Once More

Sep 17, 2025, 9:16 PM EDT - 5 weeks ago

Fangzhou Wins Gilead ‘Award of Excellence' for AI-Driven Chronic Disease Management

Sep 10, 2025, 1:38 PM EDT - 6 weeks ago

Gilead Sciences, Inc. (GILD) Presents At Baird Global Healthcare Conference 2025 Transcript

Sep 9, 2025, 2:16 PM EDT - 6 weeks ago

Gilead Sciences, Inc. (GILD) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

Sep 4, 2025, 2:15 PM EDT - 7 weeks ago

Gilead Announces Partnership With PEPFAR to Deliver Twice-Yearly Lenacapavir for HIV Prevention for up to Two Million People in Primarily Low- and Lower-Middle-Income Countries

Sep 4, 2025, 2:13 PM EDT - 7 weeks ago

US plans to bring Gilead HIV drug to market in high-burden HIV countries

Sep 4, 2025, 2:00 PM EDT - 7 weeks ago

Gilead Sciences, Inc. (GILD) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript

Sep 4, 2025, 8:30 AM EDT - 7 weeks ago

Gilead Sciences Launches Choose U™ Campaign Spotlighting the Inspiring Experiences of People Living with HIV

Sep 3, 2025, 2:30 PM EDT - 7 weeks ago

Gilead Sciences, Inc. (GILD) Presents At Cantor Global Healthcare Conference 2025 Transcript

Sep 3, 2025, 2:09 PM EDT - 7 weeks ago

Global drugmakers rush to boost US presence as tariff threat looms

ABBV AMGN AZN BIIB JNJ LLY MRK

Sep 3, 2025, 12:16 PM EDT - 7 weeks ago

Gilead starts building manufacturing hub under $32 billion planned US investments

Sep 3, 2025, 11:30 AM EDT - 7 weeks ago

Gilead Sciences Breaks Ground on New Manufacturing Hub, a Cornerstone of Its U.S. Growth and Innovation Strategy

Sep 2, 2025, 9:20 AM EDT - 7 weeks ago

Gilead Sciences: HIV Leadership Outshines Decline In COVID-19 Drug Sales

Aug 26, 2025, 3:03 AM EDT - 2 months ago

EU approves Gilead's new injection for preventing HIV

Aug 26, 2025, 3:00 AM EDT - 2 months ago

European Commission Authorizes Twice-Yearly Yeytuo® (Lenacapavir) for HIV Prevention

Aug 21, 2025, 10:21 AM EDT - 2 months ago

Gilead unit to acquire cell therapy developer Interius for $350 million

Aug 21, 2025, 8:54 AM EDT - 2 months ago

CVS Health Declines To Add Gilead's Steeply Priced New HIV Prevention Drug To Its Plans

CVS

Aug 21, 2025, 8:30 AM EDT - 2 months ago

Kite to Acquire Interius BioTherapeutics to Advance In Vivo Platform

Aug 20, 2025, 10:48 PM EDT - 2 months ago

From Stagnation To Surge: Gilead Sciences Is Entering Its Next Growth Wave

Aug 20, 2025, 4:41 PM EDT - 2 months ago

Exclusive: CVS holds off adding Gilead's new HIV prevention shot to drug coverage lists

CVS

Aug 20, 2025, 4:05 PM EDT - 2 months ago

Gilead Sciences to Present at Upcoming Investor Conferences

Aug 16, 2025, 8:15 AM EDT - 2 months ago

Our Top 10 High Growth Dividend Stocks - August 2025

APH AVGO BBVA BK EME FIX HWM

Aug 11, 2025, 6:25 PM EDT - 2 months ago

Final Trade: BSY, GDX, MNDY, GILD

GDX MNDY BSY

Aug 8, 2025, 3:36 PM EDT - 2 months ago

Gilead Sciences shares soar; analysts lift targets on HIV strength and Yeztugo outlook

Aug 8, 2025, 10:55 AM EDT - 2 months ago

Gilead Sciences Lifts Annual Outlook As Yeztugo Launch Nears

Aug 8, 2025, 5:18 AM EDT - 2 months ago

These Stocks Are Moving Most Today: Trade Desk, Expedia, Pinterest, Twilio, Gilead Sciences

EXPE PINS TTD TWLO

Aug 7, 2025, 9:39 PM EDT - 2 months ago

Gilead Sciences, Inc. (GILD) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 7:26 PM EDT - 2 months ago

Gilead Sciences Q2: The New Drug That Could Change Everything

Aug 7, 2025, 4:25 PM EDT - 2 months ago

Gilead posts flat quarterly profit, raises full-year outlook

Aug 7, 2025, 4:02 PM EDT - 2 months ago

Gilead Sciences Announces Second Quarter 2025 Financial Results

Aug 7, 2025, 2:51 PM EDT - 2 months ago

How To Earn $500 A Month From Gilead Sciences Stock Ahead Of Q2 Earnings

Aug 1, 2025, 12:01 PM EDT - 3 months ago

Pharmaceutical makers were largely unshaken by new demands from President Trump to lower drug prices, with experts saying the measures would either have modes impact or face legal challenges

ABBV AMGN AZN BMY GSK JNJ LLY

TheClockworkGroup Oct. 24 at 10:37 PM

0 · Reply

adolphfrank Oct. 24 at 9:41 PM

0 · Reply

GettnFibbywIT Oct. 24 at 6:57 PM

$XLV $SPY $GILD Kick save...And a beauty! Let's see if more shots on goal are coming below... of if price can stabilize around here sports fans:

0 · Reply

Dachshundtrader Oct. 24 at 5:08 PM

$ASMB up ~8% on almost no volume today. Not hype, not noise — just what happens when a tiny float meets a bit of quiet accumulation. Sometimes the calmest days say the most. $GILD

0 · Reply

StockOracle22 Oct. 24 at 4:29 PM

$MRK $AMGN $GILD

0 · Reply

JFDI Oct. 24 at 2:15 PM

$GILD nice hold of the 20dma

0 · Reply

Reanimated666 Oct. 24 at 1:43 PM

$GILD Fuckery

0 · Reply

RunnerSignals Oct. 24 at 10:39 AM

0 · Reply

LiquidThetaLEAPS Oct. 24 at 8:01 AM

0 · Reply

SamanthaHayward Oct. 24 at 1:22 AM

$GILD Success doesn’t happen overnight; it’s all about taking small steps! Stay steady and keep up your efforts. You’ve got this! @SamanthaHayward

0 · Reply

quincygoldsmith Oct. 23 at 11:00 PM

$GILD GILD 5M Short CounterTrend Daytrade (Buy Put to Open) 5M: Long impulse, exhaustion volume. 1H: Long impulse, volumed T1, resistance zone, volumed reaction bar. 1D: Long impulse, unvolumed T1, resistance level, volumed manipulation bar. 1M: Long impulse, volumed T1 level, resistance zone. 1Y: Long impulse, unvolumed T1, resistance zone.https://stocktwits.com/JacquelineBryant4972/message/632828478

0 · Reply

DarrellBass6729 Oct. 23 at 9:20 PM

High-conviction cluster — risk-defined entries only! Portfolio: $DIS $NEE $GILD $HD $F Why this cluster: Quiet buy-side interest + improving breadth — watch for volume confirmation. DIS shows relative strength; NEE is base-building; GILD is a stealth accumulator; HD offers sector exposure; F provides stability. Execution: Plan: small starter position, scale with a confirmed trend; respect risk. #RiskManaged #TopPicks Source: https://stocktwits.com/MarkSavage8573/message/632828492

0 · Reply

DavidAllen1688 Oct. 23 at 9:16 PM

Breaking: momentum cluster forming — watch closely! Portfolio: $GILD $RIVN $ZS $WFC $BA Why this cluster: Liquidity profile looks favorable for quick repricing once momentum confirms. GILD shows relative strength; RIVN is base-building; ZS is a stealth accumulator; WFC offers sector exposure; BA provides stability. Execution: Tip: scale in with size discipline; add on volume-confirmed strength. #AlphaHunt #Tactical Source:https://stocktwits.com/MarkSavage8573/message/632828492

1 · Reply

PatriciaMacdonald4718 Oct. 23 at 9:10 PM

High-conviction cluster — risk-defined entries only! Portfolio: $FCX $ZM $AAPL $GILD $IBM Why this cluster: Accumulation noted, range tightening, and cross-sector flow suggests rotation into these names. FCX shows relative strength; ZM is base-building; AAPL is a stealth accumulator; GILD offers sector exposure; IBM provides stability. Execution: Execution: define stop levels, use partial profit-taking on initial leg. #AlphaHunt #Tactical Source:https://stocktwits.com/GaryBrown7417/message/632828520

0 · Reply

KennethVargas1265 Oct. 23 at 7:43 PM

High-conviction cluster — risk-defined entries only! Portfolio: $WYNN $CHRW $BAC $GILD $VRTX Why this cluster: Quiet buy-side interest + improving breadth — watch for volume confirmation. WYNN shows relative strength; CHRW is base-building; BAC is a stealth accumulator; GILD offers sector exposure; VRTX provides stability. Execution: Tip: scale in with size discipline; add on volume-confirmed strength. #StocksToWatch #Momentum Source:https://stocktwits.com/GaryBrown7417/message/632828520

0 · Reply

Emmadwards Oct. 23 at 5:13 PM

$GILD Success doesn’t happen overnight; it’s all about taking small steps! Stay steady and keep up your efforts. You’ve got this! @Emmadwards

0 · Reply

BillionerOfKing Oct. 23 at 4:39 PM

$GILD Current Stock Price: $120.39 Contracts to trade: $120 GILD Oct 24 2025 Call Entry: $1.10 Exit: $2.01 ROI: 83% Hold ~29 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

JarvisFlow Oct. 23 at 3:23 PM

TD Cowen updates rating for Gilead Sciences ( $GILD ) to Buy, target set at 115 → 125.

0 · Reply

IN0V8 Oct. 23 at 2:56 PM

$GILD TD Cowen raises target price to $125 from $115

0 · Reply

LiquidThetaLEAPS Oct. 23 at 10:49 AM

LiquidTheta® LEAPS LIVE Actionable Alert Asset: $GILD Current Share Price: $121.46 Contracts: $GILD January 15, 2027 $125 Calls Scale in: $13.44- $16.43 Scale out: $20.91-$26.89 Can Easily Capture: 60% ROI Blended DTE: 450 Days | Join Elites here: https://liquidtheta.com/options

0 · Reply

SuperGreenToday Oct. 22 at 11:20 PM

$GILD Share Price: $121.47 Contract Selected: Nov 14, 2025 $120 Calls Buy Zone: $4.38 – $5.41 Target Zone: $8.08 – $9.88 Potential Upside: 74% ROI Time to Expiration: 22 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

MoneyGroupLLC Oct. 22 at 10:57 PM

Enter: $GILD NOV 14 2025 $122 CALLS Buy in Price: $4.65 - $5.70 Take Profit: $10.49 Stop Bleeding: $5.02 ROI Potential: 84% Exit Within: 2 Weeks https://moneygroup.us/alerts

0 · Reply

Market Cap	149.82B
Revenue (ttm)	28.75B
Net Income (ttm)	480.00M
EPS (ttm)	N/A
PE Ratio	15.69
Forward PE	15.05
Profit Margin	1.67%
Debt to Equity Ratio	1.27

Volume	5,438,700
Avg Vol	6,969,586
Day's Range	N/A - N/A
Shares Out	1.24B
Stochastic %K	54%
Beta	0.34
Analysts	Strong Sell
Price Target	$128.04